What Should You Expect During Actemra Infusion Treatment for Rheumatoid Arthritis in Columbia, MD?

At Jean Walter Infusion Center, we offer advanced treatment options for patients with rheumatoid arthritis, including Actemra (tocilizumab). Actemra is a proven medication that helps manage symptoms and slow the progression of this autoimmune condition.

For many patients, Actemra is most effectively administered as an intravenous (IV) infusion. At Jean Walter Infusion Center, our experienced medical team provides Actemra infusions in a safe, comfortable, and supportive environment. During an IV infusion, Actemra is slowly delivered directly into your vein over about one hour, typically once every four weeks. Our staff closely monitors patients throughout the process to ensure your well-being and to address any questions or concerns.

In addition to infusions, Actemra is also available as a subcutaneous injection (under the skin) via a pre-filled syringe or auto-injector. If this method is appropriate for you, our healthcare professionals at Jean Walter Infusion Center will provide thorough training so you can confidently administer the medication at home. The injection schedule—whether weekly or every two weeks—will be tailored to your individual treatment plan and response to therapy.

Our team at Jean Walter Infusion Center works closely with each patient to determine the most effective dosing and administration schedule. We provide comprehensive monitoring, including regular blood tests, to ensure Actemra is working effectively and to check for any potential side effects. Your safety and comfort are our top priorities.

At Jean Walter Infusion Center, an Actemra infusion session typically takes about one hour to administer the medication intravenously. However, your total visit may last longer, as our team will spend time preparing you for the infusion and monitoring you afterward to ensure your safety and comfort. Most patients are observed for approximately 30 minutes following the infusion to watch for any immediate side effects or reactions. In total, you can expect to spend about one and a half to two hours at Jean Walter Infusion Center for each Actemra session. Our healthcare providers will give you detailed instructions and let you know if your individual situation requires additional time. Your care and well-being are our top priorities throughout your visit.

Before your Actemra appointment at Jean Walter Infusion Center, our team will carefully review your medical history and current medications to ensure Actemra is the right treatment for you. You may be scheduled for blood tests at our center to assess your liver function, blood cell counts, and to screen for infections such as tuberculosis. These steps help us provide you with the safest and most effective care. Please let us know about any symptoms or concerns you may have before your visit, and our staff will provide you with detailed instructions on how to prepare, such as whether you should eat or take certain medications prior to your appointment.

At Jean Walter Infusion Center, Actemra can be administered either as an intravenous (IV) infusion or, in some cases, as a subcutaneous injection, depending on your treatment plan. If you are scheduled for an IV infusion, the process typically takes about an hour. Our experienced infusion nurses will closely monitor you for any immediate reactions, including allergic responses or infusion-related side effects, to ensure your comfort and safety throughout your visit. If you are receiving a subcutaneous injection, our staff can demonstrate proper injection techniques and supervise your first dose if needed. We encourage you to ask any questions during your appointment—our team is here to support you.

Once your treatment is complete, it’s important to watch for possible side effects, which may include headaches, high blood pressure, mild respiratory symptoms, or reactions at the injection site. The care team at Jean Walter Infusion Center may recommend regular follow-up blood tests to monitor your liver function, cholesterol levels, and blood cell counts. If you notice any unusual symptoms—such as fever, persistent cough, unexplained bruising, or signs of infection—please contact us right away.

Ongoing communication with your Jean Walter Infusion Center care team is key to managing your health and ensuring the safety and effectiveness of your Actemra therapy. We are committed to providing you with personalized, compassionate care every step of the way.

At Jean Walter Infusion Center, we offer comprehensive infusion services for patients with autoimmune conditions, including Actemra (tocilizumab) infusion therapy for the management of moderate to severe rheumatoid arthritis (RA). Actemra is a biologic medication designed for individuals who have not responded adequately to conventional disease-modifying antirheumatic drugs (DMARDs) such as methotrexate.

Actemra targets the interleukin-6 (IL-6) receptor, a key player in the body’s inflammatory process. By blocking IL-6, Actemra helps to control inflammation, reduce joint pain and swelling, and prevent further joint damage—helping patients maintain better physical function and quality of life.

At Jean Walter Infusion Center, our experienced medical team works closely with each patient and their referring rheumatologist to develop a customized long-term treatment plan. Actemra infusions are typically administered intravenously every four weeks in our comfortable, state-of-the-art facility. We also offer support for patients who may be candidates for subcutaneous injection at home, based on their individual needs.

Patient safety is our top priority. During your Actemra therapy at Jean Walter Infusion Center, you’ll receive regular monitoring for potential side effects, including infections, changes in liver enzyme levels, alterations in blood counts, and cholesterol elevations. Our infusion nurses and onsite clinicians ensure ongoing communication with your rheumatologist to assess medication effectiveness and make any necessary adjustments.

At Jean Walter Infusion Center, patient safety is our highest priority during Actemra IV therapy. We utilize a comprehensive approach to monitoring and care to ensure each patient’s well-being throughout their treatment journey.

Before starting Actemra therapy, Dr. Nasseri, MD, and our clinical team conducts a thorough evaluation to identify any contraindications, such as active infections or known allergies to Actemra. This ensures that each patient is a suitable candidate for treatment and helps minimize potential risks.

During the Actemra infusion, our experienced infusion nurses provide continuous, hands-on monitoring. Patients are observed closely for any immediate infusion reactions—including fever, chills, rash, or breathing difficulties. Vital signs (blood pressure, heart rate, temperature, and oxygen levels) are checked at regular intervals, allowing our staff to detect and address any adverse effects early.

If any concerning symptoms develop, our protocol includes immediately pausing or slowing the infusion and initiating an appropriate medical evaluation. Our nursing staff is highly trained in managing infusion reactions and can respond rapidly to ensure patient safety.

Jean Walter Infusion Center follows established premedication protocols when indicated and keeps emergency equipment and medications on-site to manage allergic or anaphylactic reactions, should they occur.

Through these comprehensive safety measures, the Jean Walter Infusion Center provides a secure, patient-centered environment for those receiving Actemra IV treatment, ensuring both immediate and long-term safety throughout your infusion experience. For more information, contact us or book an appointment online. We are conveniently located at 5500 Knoll North Dr, Suite 250A, Columbia, MD 21045. We serve patients from Columbia, MD, Ellicott City MD, Laurel MD, Clarksville MD, Fulton MD, and surrounding areas.